Finance > Venture Deals Database > Venture Transactions Database > Monthly Deals (All) > October 2007 VC Transactions
Tengion

Tech Company Financing Transactions

Tengion Funding Round

Tengion closed a $33 million Series C financing round on 10/15/2007. Backers included Deerfield Capital, Bain Capital Ventures and Healthcap Venture Capital.

Transaction Overview

Company Name

Tengion

Announced On

10/15/2007

Transaction Type

Venture Equity

Amount

$33,000,000

Round

Series C

Investors

Deerfield Capital (Lead Investor) (Howard Furst)

Bain Capital Ventures (James Nahirny)

Healthcap Venture Capital

Horizon Technology Finance

Johnson & Johnson Development Corporation (David Holveck)

L Capital Partners

Oak Investment Partners

Oxford Finance

Quaker Partners (Brenda Gavin)

Proceeds Purpose

Proceeds from this financing will be used to advance the late-stage clinical development of the Tengion Neo-Bladder Augment�, currently being evaluated in two Phase 2 trials, as well as to accelerate expansion of Tengion's novel regenerative medicine platform into the development of other autologous organs and tissues in the genitourinary and cardiovascular systems.

Company Information

Company Status

Publicly-held

Industry

Biopharmaceutical

Mailing Address

3929 Westpoint Blvd. G
Winston-Salem, NC 27103
USA

Phone

(336) 722-5855

Website

www.tengion.com

Email Address

[email protected]

Overview

Tengion (NASDAQ: TNGN) is a leader in developing autologous neo-organs and tissues, such as bladders, that are derived from the patient's own (autologous) cells.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

John Miclot

Chief Financial Officer

Brian Davis

Chief Scientific Officer

Tim Bertram

Chief Technical Officer

Deepak Jain

Browse more venture capital transactions:

Prev: 10/15/2007: Cellpoint Diagnostics venture capital transaction
Next: 10/15/2007: TokBox venture capital transaction

Share this article

Where The Data Comes From

Our team works diligently to report on funding rounds that are announced publicly. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary